ViroVet
The computed 12-month bankruptcy probability of ViroVet is 0.3% (very low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 10 yrs |
| Board | 14 |
| Locations | 1 |
| Publications | 55 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 01-07-2025 | 2025-00205904 |
| 31-12-2023 | volledig | 27-05-2024 | 2024-00096420 |
| 31-12-2022 | volledig | 24-05-2023 | 2023-00094930 |
| 31-12-2021 | volledig | 16-06-2022 | 2022-20066095 |
| 31-12-2020 | volledig | 07-06-2021 | 2021-17700020 |
| 31-12-2019 | volledig | 26-05-2020 | 2020-13000397 |
| 31-12-2018 | volledig | 28-05-2019 | 2019-14900173 |
| 31-12-2017 | volledig | 31-05-2018 | 2018-15300473 |
| 31-12-2016 | volledig | 22-05-2017 | 2017-12900294 |
-
VIVES PARTNERSLegal entityDirector· perm. rep.: Yannick VancoppenolleState Gazette act 24091814 (18-06-2024)Current31-01-2024 → present
-
Esbee BVLegal entityManaging director· perm. rep.: Erwin BlomsmaState Gazette act 22067467 (07-06-2022)Current07-06-2022 → present
-
Current30-09-2021 → present
-
BIOTECH FONDS VLAANDERENLegal entityDirector· perm. rep.: GOOSSENS FilipState Gazette act 21074597 (23-06-2021)Current09-02-2021 → present
-
SOPARTECLegal entityDirector· perm. rep.: VANCOPPENOLLE YannickState Gazette act 21074597 (23-06-2021)Current10-07-2020 → present
-
Current06-06-2020 → present
-
SEVENTURE PARTNERS SALegal entityDirector· perm. rep.: GERBE Laetitia AnnieState Gazette act 20326282 (15-06-2020)Current28-05-2020 → present
-
Biotech Fonds VlaanderenLegal entityDirector· perm. rep.: WILS Kenneth Maria J.State Gazette act 20326282 (15-06-2020)Current07-04-2020 → present
-
ESBEELegal entityManaging director· perm. rep.: Erwin BlomsmaState Gazette act 17115990 (09-08-2017)Current12-07-2017 → present
-
Current28-12-2016 → present
-
Current28-12-2016 → present
-
SOPARTECLegal entityDirector· perm. rep.: Filip GoossensState Gazette act 17016279 (30-01-2017)Current28-12-2016 → present
-
Current17-08-2015 → present
3 events
- 30-01-2017 Appointed· Director
- 17-08-2015 Appointed· Manager
- 13-08-2015 Resigned· Manager
-
Esbee BVBALegal entityManager· perm. rep.: Erwin BlomsmaState Gazette act 15125347 (02-09-2015)Current13-08-2015 → present
Former directors (4)
-
Former— → 30-09-2021
-
Former— → 06-06-2020
-
Former— → 30-01-2017
-
EsbeeLegal entityDirector· perm. rep.: Erwin BlomsmaState Gazette act 17016279 (30-01-2017)Former— → 28-12-2016
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Baker Tilly Belgium bedrijfsrevisorenCurrent Company auditor · represented by Peter Weyers |
— | 17-01-2017 → present |
| BV PwC BedrijfsrevisorenCurrent Statutory auditor · represented by Griet Helsen |
— | 19-06-2020 → present |
| NACE primary | 72101 |
| Legal form | Public limited company(014) |
| Incorporation | 06-08-2015 |
| Status | Active |
| Postal code | 3001 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24514C0015/00Z002 | Flanders | 2,862 m² | 1 · 838 m² | 8.7 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-03-2026 1 director appointed, 1 resigning
- Griet Helsen — Commissaris
- Kevin Veestraeten — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Kevin Veestraeten",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}23-03-2026 Griet Helsen reappointed as statutory auditor
- Griet Helsen — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Griet Helsen BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-07-01",
"evidence_quote": "De algemene vergadering neemt akte van de wijziging van de vaste vertegenwoordiger van de vennootschap PwC Bedrijfsrevisoren BV, met zetel te 1831 Diegem, Culliganlaan 5, en met ondernemingsnummer 0429.501.944, die overeenkomstig artikel 3:60 WVV vanaf 1 juli 2025 zal vertegenwoordigd worden door Gr",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2025-07-01"
},
"rep_rotation_new_rep": "Griet Helsen",
"rep_rotation_old_rep": "Kevin Veestraeten",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Bijzondere volmacht wordt verleend aan Xerius Contact VZW, met zetel te Brouwersvliet 4, bus 1, 2000 Antwerpen en met ondernemingsnummer 0410.958.217, RPR Antwerpen, afdeling Antwerpen met inbegrip van elke bestuurder, vertegenwoordiger, werknemer, bediende of aangestelde van Xerius Contact VZW, spe",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "sole_shareholder_declaration",
"role": null,
"person": {
"rrn": null,
"name": "Viktorija Coric",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-23",
"filing_date": "2026-03-13",
"act_kind_objet": "Commissaris"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-12-04",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Viktorija Coric",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}24-01-2025 1 director appointed, 1 resigning
- Erwin Blomsma — Gedelegeerd bestuurder
- Seventure Partners SA — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": null,
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": "0661.711.333",
"name": "Seventure Partners SA",
"address": "Rue de Monttessuy 5-7, 75007 Parijs",
"country": "FR",
"legal_form": "SA"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-10",
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder, met ingang vanaf oktober 2024: - de vennootschap naar Frans recht \u0022Seventure Partners SA\u0022",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Kevin Veestraeten",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0429.501.944",
"name": "PwC Bedrijfsrevisoren BV/ PwC Reviseurs d\u0027Entreprises SRL",
"address": "Culliganlaan 5, 1831 Diegem",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-07-15",
"evidence_quote": "PwC Bedrijfsrevisoren BV/ PwC Reviseurs d\u0027Entreprises SRL stelt in overeenstemming met artikel 3:60 van het Wetboek van Vennootschappen en Verenigingen, in haar hoedanigheid van Commissaris, Kevin Veestraeten BV aan als haar vaste vertegenwoordiger vanaf 15 juli 2024 ter vervanging van Griet Helsen ",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2024-07-15"
},
"rep_rotation_new_rep": "Kevin Veestraeten BV",
"rep_rotation_old_rep": "Griet Helsen BV",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "Gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Erwin Blomsma",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Esbee BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-24",
"filing_date": "2024-11-15",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-11-15",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}24-01-2025 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}24-01-2025 1 director appointed, 1 resigning
- Kevin Veestraeten BV — Vaste vertegenwoordiger commissaris
- GERBE Laetitia — Vaste vertegenwoordiger commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "GERBE Laetitia",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Kevin Veestraeten BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}18-06-2024 1 director appointed, 1 resigning
- VIVES PARTNERS SRL — Bestuurder
- SOPARTEC SA — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VIVES PARTNERS SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC SA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}18-06-2024 1 director appointed, 1 resigning
- Yannick Vancoppenolle — Bestuurder
- SOPARTEC SA — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC SA",
"address": null,
"birth_date": null
},
"effective_date": "2024-01-31",
"evidence_quote": "\u0022SOPARTEC SA\u0022, met zetel te 1348 Louvain-la-Neuve, Place de l\u0027Universit\u00E9 16 / 27 en met ondernemingsnummer 0402.978,679 wordt vervangen door \u0022VIVES PARTNERS SRL\u0022, met zetel te 1300 Waver, Chemin du Stocquoy 1 en met ondernemingsnummer 1004.227.835, met als vaste vertegenwoordiger Yannick Vancoppenol"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yannick Vancoppenolle",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1004227835",
"name": "VIVES PARTNERS SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-01-31",
"evidence_quote": "\u0022SOPARTEC SA\u0022, met zetel te 1348 Louvain-la-Neuve, Place de l\u0027Universit\u00E9 16 / 27 en met ondernemingsnummer 0402.978,679 wordt vervangen door \u0022VIVES PARTNERS SRL\u0022, met zetel te 1300 Waver, Chemin du Stocquoy 1 en met ondernemingsnummer 1004.227.835, met als vaste vertegenwoordiger Yannick Vancoppenol"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}09-02-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}09-02-2024 1 director appointed, 1 resigning
- BEKE Thomas — Bestuurder
- GUNN George William — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUNN George William",
"address": "Charibury Road 24, OX2 6UU Oxford, Verenigd Koninkrijk",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-10-06",
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder, met ingang vanaf 6 oktober 2023:",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": {
"kbo": "0454.215.168",
"name": "Biotech Fonds Vlaanderen",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"country": "BE",
"legal_form": "NV"
},
"statutory": "coopted",
"compensated": null,
"effective_date": "2023-11-13",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer GOOSSENS Filip te vervangen door de heer BEKE Thomas, woonplaats kiezende te 1000 Brussel, Oude Graanmarkt 63, als vaste vertegenwoordige",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "BEKE Thomas",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEKE Thomas",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0454.215.168",
"name": "Biotech Fonds Vlaanderen",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": "2023-11-13",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer GOOSSENS Filip te vervangen door de heer BEKE Thomas, woonplaats kiezende te 1000 Brussel, Oude Graanmarkt 63, als vaste vertegenwoordige",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": "GOOSSENS Filip",
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Leuven",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-09",
"filing_date": "2024-02-01",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-11-29",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "NV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Esbee BV",
"person_name": null,
"org_rep_person_name": "Erwin Blomsma",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}09-02-2024 1 director appointed, 1 resigning
- BEKE Thomas — Vaste vertegenwoordiger
- GUNN George William — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUNN George William",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "BEKE Thomas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}27-06-2023 1 director appointed, 1 resigning
- BV PwC Bedrijfsrevisoren — Commissaris
- BV PwC Bedrijfsrevisoren — Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}27-06-2023 Griet Helsen reappointed as statutory auditor
- Griet Helsen — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering benoemt de BV PwC Bedrijfsrevisoren, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als Commissaris voor een termijn van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}20-04-2023 Capital increase of €920,900.24 to €5,431,311.67
- €4.510.411,43 → €5.431.311,67
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 920900.24,
"currency": "EUR",
"after_eur": 5431311.67,
"delta_eur": 920900.24,
"before_eur": 4510411.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 920.900,24 EUR, om het van 4.510.411,43 EUR te brengen op 5.431.311,67 EUR, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 578526.31,
"currency": "EUR",
"after_eur": 6009837.98,
"delta_eur": 578526.31,
"before_eur": 5431311.67,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap een tweede maal te verhogen met 578.526,31 EUR, om het te brengen van 5.431.311,67 EUR op 6.009.837,98 EUR, door incorporatie van het volledige bedrag van de uitgiftepremie in het kapitaal",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 0.08,
"currency": "EUR",
"after_eur": 6009838.06,
"delta_eur": 0.08,
"before_eur": 6009837.98,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "Het kapitaal van de vennootschap bedraagt zes miljoen negenduizend achthonderdachtendertig euro zes cent (\u20AC 6.009.838,06)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}20-04-2023 Capital increase of €1,499,426.55 to €6,009,837.98
- €4.510.411,43 → €6.009.837,98
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6009837.98,
"delta_eur": 1499426.5500000007,
"before_eur": 4510411.43,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}20-04-2023 Capital increase of €920,900.24 to €5,431,311.67
- €4.510.411,43 → €5.431.311,67
- Inbreng in geld · Apport en numéraire
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 5431311.67,
"delta_eur": 920900.24,
"before_eur": 4510411.43,
"share_emission": {
"agio_eur": 578526.31,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte C",
"n_new_shares": 48932,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 30.65
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 920900.24,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 6009837.98,
"delta_eur": 578526.31,
"before_eur": 5431311.67,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 578526.31,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-20",
"filing_date": "2023-04-18",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-04-06",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"acht volmachten",
"het verslag van het bestuursorgaan",
"het verslag van de commissaris opgesteld overeenkomstig artikel 7:155 WVV",
"het verslag van het bestuursorgaan en het verslag van de commissaris opgesteld overeenkomstig artikel 7:180 WVV",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26666,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105458,
"class_name": "Bevoorrechte A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 76980,
"class_name": "Bevoorrechte B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 79513,
"class_name": "Bevoorrechte C Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}23-06-2022 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-06-16",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}23-06-2022 Capital decrease of €5,420,708.96 to €2,010,411.43
- €7.431.120,39 → €2.010.411,43
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_decrease",
"amount": 5420708.96,
"currency": "EUR",
"after_eur": 2010411.43,
"delta_eur": -5420708.96,
"before_eur": 7431120.39,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, in toepassing van artikel 7:210 van het Wetboek van vennootschappen en verenigingen, te verminderen ten belope van 5.420.708,96 EUR, om het te brengen van 7.431.120,39 EUR op 2.010.411,43 EUR, zonder vernietiging van aandelen.",
"contribution_type": null
},
{
"kind": "capital_increase",
"amount": 293883.41,
"currency": "EUR",
"after_eur": 2304294.84,
"delta_eur": 293883.41,
"before_eur": 2010411.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 293.883,41 EUR, om het van 2.010.411,43 EUR te brengen op 2.304.294,84 EUR, door inbreng in geld en met de uitgifte van 30.581 nieuwe Bevoorrechte C Aandelen",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 2206116.59,
"currency": "EUR",
"after_eur": 4510411.43,
"delta_eur": 2206116.59,
"before_eur": 2304294.84,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap een tweede maal te verhogen met 2.206.116,59 EUR, om het te brengen van 2.304.294,84 EUR op 4.510.411,43 EUR, door incorporatie van het volledige bedrag van de uitgiftepremie in het kapitaal en zonder uitgifte van nieuwe aandelen.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}23-06-2022 Capital decrease of €5,420,708.96 to €2,010,411.43
- €7.431.120,39 → €2.010.411,43
- 5 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 2010411.43,
"delta_eur": -5420708.96,
"before_eur": 7431120.39,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 2304294.84,
"delta_eur": 293883.41,
"before_eur": 2010411.43,
"share_emission": {
"agio_eur": 2206116.59,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte C",
"n_new_shares": 30581,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 81.74
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 293883.41,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 30581,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 4510411.43,
"delta_eur": 2206116.59,
"before_eur": 2304294.84,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 2206116.59,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-06-23",
"filing_date": "2022-06-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-06-16",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26666,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105458,
"class_name": "Bevoorrechte A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 76980,
"class_name": "Bevoorrechte B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 30581,
"class_name": "Bevoorrechte C Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}23-06-2022 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}23-06-2022 Capital increase of €2,500,000 to €4,510,411.43
- €2.010.411,43 → €4.510.411,43
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 4510411.43,
"delta_eur": 2500000.0,
"before_eur": 2010411.43,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}07-06-2022 2 directors appointed, 1 resigning
- HAESEN Patrik — Bestuurder
- Erwin Blomsma — Gedelegeerd bestuurder
- Luc Basstanie — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HAESEN Patrik",
"address": null,
"birth_date": null
},
"effective_date": "2021-09-30",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Agri Investment Fund CVBA bij besluit van de Raad van Bestuur de dato 5 oktober 2021: HAESEN Patrik, "
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Basstanie",
"address": null,
"birth_date": null
},
"effective_date": "2021-09-30",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Agri Investment Fund CVBA bij besluit van de Raad van Bestuur de dato 5 oktober 2021: HAESEN Patrik, "
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Erwin Blomsma",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Esbee BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Esbee BV, vertegenwoordigd door Erwin Blomsma Gedelegeerd bestuurder"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}07-06-2022 HAESEN Patrik appointed as director
- HAESEN Patrik — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HAESEN Patrik",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}23-06-2021 3 directors appointed, 1 resigning
- SIENAERT Ilse — Bestuurder
- VANCOPPENOLLE Yannick — Bestuurder
- GOOSSENS Filip — Bestuurder
- Pierre Naassens — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SIENAERT Ilse",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-06",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Gemma Frisius Fonds K.U. Leuven NV bij besluit van de Raad van Bestuur de dato 15 juli 2020: SIENAERT"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Naassens",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-06",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Gemma Frisius Fonds K.U. Leuven NV bij besluit van de Raad van Bestuur de dato 15 juli 2020: SIENAERT"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VANCOPPENOLLE Yannick",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0402978679",
"name": "Sopartec",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-07-10",
"evidence_quote": "de naamloze vennootschap \u0022Sopartec\u0022, met zetel te 1348 Louvain-la-Neuve, Chemin du Cyclotron 6 en met ondernemingsnummer 0402.978.679 heeft beslist om de heer GOOSSENS Filip als vaste vertegenwoordiger te vervangen door de heer VANCOPPENOLLE Yannick, wonende te 5080 Warisoulx, Rue de Namur 28 met in"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0454215168",
"name": "Biotech Fonds Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-02-09",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer WILS Kenneth te vervangen door de heer GOOSSENS Filip, wonende te 1910 Kampenhout, Van Bellinghenlaan 3 als vaste vertegenwoordiger met i"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}23-06-2021 3 directors appointed, 3 resigning
- SIENAERT Ilse — Bestuurder
- VANCOPPENOLLE Yannick — Vaste vertegenwoordiger
- GOOSSENS Filip — Vaste vertegenwoordiger
- Pierre Naassens — Bestuurder
- GOOSSENS Filip — Vaste vertegenwoordiger
- WILS Kenneth — Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SIENAERT Ilse",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Naassens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "VANCOPPENOLLE Yannick",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "WILS Kenneth",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}19-06-2020 Griet Helsen reappointed as statutory auditor
- Griet Helsen — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering benoemt de BV PwC Bedrijfsrevisoren, met zetel te 1932 Sint-Stevens-Woluwe Woluwedal 18, als Commissaris voor een termijn van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}19-06-2020 1 director appointed, 1 resigning
- BV PwC Bedrijfsrevisoren — Commissaris
- Griet Helsen — Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 Capital increase of €6,092,931.52 to €11,544,734.35
- €5.451.802,83 → €11.544.734,35
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 11544734.35,
"delta_eur": 6092931.52,
"before_eur": 5451802.83,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}15-06-2020 9 directors appointed, 1 resigning
- Biotech Fonds Vlaanderen — Bestuurder
- Seventure Partners SA — Bestuurder
- Biotech Fonds Vlaanderen — Bestuurder
- Luc Jozef Maria Basstanie — Bestuurder
- George William Gunn — Bestuurder
- Pierre Eugène Naassen — Bestuurder
- SOPARTEC — Bestuurder
- Capricorn Partners — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "David Jacques Martine Devigne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Seventure Partners SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Jozef Maria Basstanie",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "George William Gunn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Eug\u00E8ne Naassen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Capricorn Partners",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ESBEE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 2 directors appointed
- WILS Kenneth Maria J. — Bestuurder
- GERBE Laetitia Annie — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "WILS Kenneth Maria J.",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-04-07",
"evidence_quote": "I. De vergadering erkent en bekrachtigt de benoeming van de volgende bestuurder, geco\u00F6pteerd bij besluit van de Raad van Bestuur de dato 7 april 2020: de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63, vast vertegenwoordigd door de heer WILS Kenneth M"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GERBE Laetitia Annie",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Seventure Partners SA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-05-28",
"evidence_quote": "De vergadering beslist op op voorstel van \u0022AVF FPCI\u0022, te benoemen als bestuurder, vanaf achtentwintig mei tweeduizend twintig en voor een duur die de zes jaar niet te boven gaat: de vennootschap naar Frans recht \u0022Seventure Partners SA\u0022, met zetel te 5-7 Rue de Monttessuy, 75007 Parijs, Frankrijk, va"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ViroVet |